Mayne Pharma Group Limited

ASX (AUD): Mayne Pharma Group Limited (MYX)

Last Price

4.55

Today's Change

-1.93 (29.78%)

Day's Change

4.31 - 4.63

Trading Volume

4,910,347

Overview

Market Cap

369 Million

Shares Outstanding

81 Million

Avg Volume

784,462

Avg Price (50 Days)

7.02

Avg Price (200 Days)

5.42

PE Ratio

-2.92

EPS

-1.56

Earnings Announcement

21-Aug-2025

Previous Close

6.48

Open

4.50

Day's Range

4.31 - 4.63

Year Range

3.74 - 7.31

Trading Volume

4,910,347

Price Change Highlight

1 Day Change

-29.78%

5 Day Change

-27.20%

1 Month Change

-35.37%

3 Month Change

-36.81%

6 Month Change

8.85%

Ytd Change

-5.21%

1 Year Change

-16.51%

3 Year Change

-24.17%

5 Year Change

-48.88%

10 Year Change

-79.51%

Max Change

-53.67%

News and Blogs
Latest Hottest Following

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Drug Manufacturers—General

Description:

Mayne Pharma Group Limited, a specialty pharmaceutical company, manufactures and sells branded and generic pharmaceutical products in Australia, New Zealand, the United States, Canada, Europe and Asia. The company operates through four segments: Metrics Contract Services, International, Branded Products, and Portfolio Products. It provides oral drug delivery systems; and contract pharmaceutical development, manufacturing, and analytical services to third-party customers, as well as distributes specialty pharmaceutical products in the dermatology, women's health, and infectious disease therapeutic areas. The company was formerly known as Halcygen Pharmaceuticals Limited and changed its name to Mayne Pharma Group Limited in November 2010. Mayne Pharma Group Limited was incorporated in 2005 and is based in Salisbury South, Australia.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment